Stockscreener 앱 받기
5.38
0.65%
0.010
전일 마감가:
$5.37
열려 있는:
$5.39
하루 거래량:
1.54M
Relative Volume:
0.39
시가총액:
$1.65B
수익:
$248.37M
순이익/손실:
$11.74M
주가수익비율:
107.60
EPS:
0.05
순현금흐름:
$18.24M
1주 성능:
+1.41%
1개월 성능:
+17.76%
6개월 성능:
+9.19%
1년 성능:
-13.66%
1일 변동 폭
$5.355
$5.55
1주일 범위
$5.185
$5.62
52주 변동 폭
$3.3812
$7.63
맨카인드 Stock (MNKD) Company Profile
명칭
Mannkind Corp
전화
818-661-5000
주소
1 CASPER STREET, DANBURY, CA
MNKD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MNKD
Mannkind Corp
|
5.38 | 1.65B | 248.37M | 11.74M | 18.24M | 0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
406.10 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
607.14 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.79 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
776.00 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
345.21 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
맨카인드 Stock (MNKD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-16 | 재개 | H.C. Wainwright | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-10 | 개시 | Wedbush | Outperform |
| 2024-12-20 | 개시 | Wells Fargo | Overweight |
| 2024-12-19 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2023-10-10 | 개시 | Wedbush | Outperform |
| 2021-05-14 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-12-24 | 개시 | Oppenheimer | Outperform |
| 2019-10-25 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-05-14 | 개시 | BTIG Research | Buy |
| 2019-03-04 | 개시 | SVB Leerink | Outperform |
| 2019-02-22 | 개시 | SVB Leerink | Outperform |
| 2018-02-28 | 다운그레이드 | Maxim Group | Hold → Sell |
| 2017-11-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2017-10-10 | 개시 | H.C. Wainwright | Buy |
| 2017-10-06 | 재확인 | Maxim Group | Buy |
| 2017-08-11 | 개시 | Maxim Group | Buy |
| 2016-05-10 | 재확인 | Piper Jaffray | Underweight |
| 2016-05-10 | 재확인 | RBC Capital Mkts | Underperform |
| 2016-01-06 | 재확인 | Piper Jaffray | Underweight |
| 2016-01-06 | 재확인 | RBC Capital Mkts | Underperform |
| 2015-11-04 | 다운그레이드 | RBC Capital Mkts | Outperform → Underperform |
| 2015-09-09 | 다운그레이드 | Piper Jaffray | Neutral → Underweight |
| 2015-08-03 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-05-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2015-05-11 | 재확인 | MLV & Co | Hold |
| 2015-04-16 | 재확인 | RBC Capital Mkts | Outperform |
모두보기
맨카인드 주식(MNKD)의 최신 뉴스
Key metrics from MannKind Corporation’s quarterly dataCEO Change & Precise Entry and Exit Recommendations - newser.com
Is MannKind Corporation a good long term investmentSector ETF Performance & Take Advantage of Momentum Stocks - earlytimes.in
MannKind (MNKD) Appoints New Chief Medical Officer - GuruFocus
MNKD Appoints New Chief Medical Officer to Strengthen Leadership Team - GuruFocus
MannKind appoints Ajay Ahuja as chief medical officer - Investing.com
MannKind Corporation Appoints Dr. Ajay Ahuja as Chief Medical Officer - Quiver Quantitative
MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer - Yahoo Finance
Will MannKind Corporation (NNFN) stock see insider accumulationJuly 2025 Rallies & Stock Timing and Entry Methods - newser.com
Is MannKind Corporation (NNFN) stock undervalued historically2025 Technical Overview & Stepwise Swing Trade Plans - newser.com
Why MannKind Corporation (NNFN) stock is trending on social mediaEntry Point & High Accuracy Swing Trade Signals - newser.com
Will a bounce in MannKind Corporation offer an exitEarnings Overview Summary & Community Verified Swing Trade Signals - newser.com
Non Tuberculous Mycobacterial Infections Market Dynamics - openPR.com
MannKind (NASDAQ:MNKD) Shares Down 5%Time to Sell? - MarketBeat
MannKind (NASDAQ:MNKD) Earns Buy Rating from HC Wainwright - MarketBeat
MannKind Corporation (NASDAQ:MNKD) Sees Significant Drop in Short Interest - MarketBeat
Insider Selling: MannKind (NASDAQ:MNKD) Insider Sells 47,000 Shares of Stock - MarketBeat
Goldman Sachs Group Inc. Sells 780,939 Shares of MannKind Corporation $MNKD - MarketBeat
MannKind (NASDAQ:MNKD) Trading Down 4.2%Should You Sell? - MarketBeat
MNKD: HC Wainwright & Co. Reiterates Buy Rating with $11 Target - GuruFocus
MannKind (MNKD) chief people officer sells $250,980 in stock By Investing.com - Investing.com UK
Insider Sell Alert: Stuart Tross Sells 47,000 Shares of MannKind Corp (MNKD) - GuruFocus
MannKind (MNKD) chief people officer sells $250,980 in stock - Investing.com
Hedge Fund Bets: Can MannKind Corporation outperform under higher oil prices2025 Earnings Surprises & AI Powered Market Entry Strategies - خودرو بانک
Hedge Fund Moves: Can MannKind Corporation stock double in the next year2025 Performance Recap & Growth Focused Entry Reports - khodrobank.com
Can MannKind Corporation outperform in the next rallyQuarterly Risk Review & Verified Swing Trading Watchlist - خودرو بانک
Weekly Recap: What is MannKind Corporations P E ratio telling usQuarterly Investment Review & Consistent Return Strategy Ideas - خودرو بانک
Analyst Calls: Can MannKind Corporation navigate macro headwindsGold Moves & Consistent Profit Trading Strategies - خودرو بانک
Jacobs Levy Equity Management Inc. Increases Stock Holdings in MannKind Corporation $MNKD - MarketBeat
Millennium Management LLC Purchases 2,375,198 Shares of MannKind Corporation $MNKD - MarketBeat
맨카인드 (MNKD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.97%
자본화:
|
볼륨(24시간):